Evidence map›Paper›PMID 41676090›Full record

ArticleFrontiers in medicine2026

Trends in asthma and pneumonia-related mortality in the United States: a CDC wonder database analysis (1999-2023).

Junsheng Jiang, Lina Qi, Shenggang Ding

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Junsheng JiangDepartment of Pediatrics, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Lina QiDepartment of Pediatrics, The First People's Hospital of Linping District, Hangzhou, China.
Shenggang DingDepartment of Pediatrics, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study seeks to investigate mortality trends associated with the simultaneous occurrence of asthma and pneumonia among U.S over the period from 1999 to 2023. Methods: CDC WONDER was used to identify asthma and pneumonia related deaths that occurred within the United States from 1999 to 2023. Crude and age-adjusted mortality rates (AAMR) were calculated, as well as annual percent change and weighted average annual percent change with 95% confidence intervals for the AAMRs. The Joinpoint Regression Program was used to determine trends in mortality within the study period. Joinpoint regression analysis was employed to determine annual percentage changes (APCs) and assess statistical significance ( Results: From 1999 to 2023, male patients demonstrated greater mortality rates from pneumonia and asthma compared to females. When stratified by race and ethnicity, Black patients had the highest AAMR over the study period at 29.21 per 100,000 people in 1999, as well as the most significant reduction in AAMR to 13.91 per 100,000 people in 2023. Additionally, AAMRs were consistently higher in rural areas compared to urban locations. By age group, patients aged 85+ had the highest overall crude mortality rate at 747.90 per 100,000 people in 1999, with the lowest rate in ages 5-14 at 0.51 per 100,000 people in 1999. Conclusions: This study highlight epidemiological differences in asthma- and pneumonia-related death. Significant disparities in mortality rates were noted in older-aged, male, Black, and rural patients.

Indexed as

age-adjusted mortality ratesasthmaCDCpneumoniathe United States

Identifiers

PMID41676090
PMCPMC12886384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.